Increase of interferon-gamma-inducible CXC chemokine CXCL10 serum levels in patients with active Graves' disease, and modulation by methimazole therapy - Antonelli, A; Rotondi, M; Fallahi, P (Clin Endocrinol (Oxf), 2006)
et al.